ESR1 and triple-negative breast carcinoma: Piperine was found to inhibit cell proliferation of triple negative breast cancer deficient in p53 (TNBC), estrogen receptor positive breast cancer cell, p53 deficient and estrogen receptor positive that express p53 (Huovinen et al., 2011).